Furthermore, several genes, such as TREM1 and VSIG4 in our risk model were also shown to have prognostic significance and may prove to be a novel, efficacious strategy for the treatment of NSCLC 32,33. Here, TREM1 is linked to non-small cell lung carcinoma.